NAS
CDNA icon

Nykredit A/S’s CareDx CDNA Stock Holding History

Nykredit A/S’s Portfolio CDNA Stock Details CDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$24.6K Buy
+862
New +$18.8K ﹤0.01% 1676

Other funds holding CDNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Nykredit A/S's CDNA Position: Q2 2026 in Review

Nykredit A/S opened a new position in CareDx (CDNA) in Q2 2026: 862 shares worth $24.6K. The stake represents ﹤0.01% of the portfolio and ranks #1676 among its holdings.

149 funds tracked by Wall St. Rank hold CDNA as of Q2 2026.

  • Nykredit A/S held 862 shares of CareDx worth $24.6K as of Q2 2026.
  • CareDx was a new Nykredit A/S position in Q2 2026.
  • CareDx made up ﹤0.01% of Nykredit A/S's portfolio in Q2 2026, its #1676 holding.
  • 149 funds tracked by Wall St. Rank held CareDx as of Q2 2026.

Based on Nykredit A/S's 13F filing for Q2 2026, filed 13 Aug 2026.